Full Text View
Tabular View
No Study Results Posted
Related Studies
Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder
This study is currently recruiting participants.
Study NCT00523718   Information provided by Yale University
First Received: August 29, 2007   Last Updated: October 30, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obsessive-Compulsive Disorder
Additional conditions recognized in this trial
Disease
More general conditions related to this trial
Anxiety Disorders
Mental Disorders
Pathologic Processes
Interventions listed in this trial
riluzole
placebo
Additional drug interventions recognized in this trial
Serotonin Uptake Inhibitors
More general drug interventions related to this trial
Anticonvulsants
Central Nervous System Agents
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Serotonin Agents
Therapeutic Uses
Sponsors listed in this trial
Yale University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services